z-logo
Premium
Exosomes derived from regulatory T cells ameliorate acute myocardial infarction by promoting macrophage M2 polarization
Author(s) -
Hu Hao,
Wu Jiawei,
Cao Cheng,
Ma Likun
Publication year - 2020
Publication title -
iubmb life
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.132
H-Index - 113
eISSN - 1521-6551
pISSN - 1521-6543
DOI - 10.1002/iub.2364
Subject(s) - microvesicles , myocardial infarction , apoptosis , flow cytometry , macrophage polarization , cardiac function curve , macrophage , medicine , immunology , cancer research , chemistry , microrna , heart failure , in vitro , gene , biochemistry
Acute myocardial infarction (AMI) is a serious ischemic heart disease. Regulatory T cells (Tregs) participate in AMI. This article aims to investigate the mechanism of action of Tregs in AMI. We constructed AMI mouse model. Then, AMI mouse and mouse macrophages (RAW264.7) were treated with Tregs or Treg‐derived exosomes. The cardiac function of mice was detected. Triphenyl‐tetrazolium chloride and TdT‐mediated dUTP nick‐end labeling staining were performed to detect the myocardial infarct size or apoptosis. The proportions of macrophages were analyzed by flow cytometry. Enzyme linked immunosorbent assay and quantitative real‐time PCR was performed to estimate the levels of cytokines and genes. We found that Tregs ameliorated cardiac function, reduced myocardial infarct size and inhibited apoptosis of myocardial cells in AMI mice. Moreover, Treg‐derived exosomes reduced myocardial infarct size and repressed apoptosis of myocardial cells in AMI mice. Furthermore, Treg‐derived exosomes suppressed the expression of M1 macrophage markers, and promoted the expression of M2 macrophage markers in myocardial tissues of AMI mice and RAW264.7 cells. In conclusion, our work demonstrates that exosomes derived from Tregs ameliorate AMI by promoting macrophage M2 polarization. Thus, Tregs may be an essential cell for AMI treatment.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here